Delivery Order SPE2DB22D3004-SPE2DB25FSF15
- Not listed
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 30, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TREMFYA 200 mg/2 mL pens valued at $21,765.75 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 5, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections valued at $7,255.25. This firm fixed-price, competitively awarded delivery order carries an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating the award was made through open...
- The Defense Logistics Agency awarded a $14,510.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for TREMFYA 200 mg/2 mL pen injections. This is a non-set-aside competitive award with a completion date of September 4, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $21,941.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical supply on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $14,510.52 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for TREMFYA 200 mg/2 mL pen injections. This contract, classified as a firm fixed price delivery order with no set-aside designation, is scheduled for completion by September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic immunosuppressant medication used to treat psoriasis and psoriatic...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen (2 mL), a pharmaceutical product for military and federal healthcare use. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is registered in the System for Award Management...
- The Defense Logistics Agency awarded a $21,765.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 12, 2025, with an ultimate completion date of September 3, 2025. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat autoimmune conditions including psoriasis and psoriatic arthritis,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSF15Delivery Order
The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 28, 2025, with completion targeted for September 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies and medications to Defense Health Agency, the U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capability to fulfill competitive federal medical procurement requirements is reflected through its extensive contract portfolio with DLA, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for TREMFYA, a specialty pharmaceutical treatment, exemplifies the company's role as a key vendor within the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/28/25 |